Is Ketorolac Tromethamine Tablet in shortage?
Ketorolac Tromethamine Tablet is listed by FDA as being discontinued by at least one maker (updated Apr 20, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)
Discontinuation of the manufacture of the drug
Maker contact: 877-446-3679
FDA recalls of Ketorolac Tromethamine
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Ketorolac Tromethamine Tablet:
- Aspiro Pharma Limited recalls Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx
- Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill,
- Apotex Corp. recalls Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 10 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario,
- Nephron Sc Inc recalls Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL single dose vials, Rx Only, Nephron
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only,
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vials (NDC
- Fresenius Kabi USA, LLC recalls Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL
- Hikma Pharmaceuticals USA Inc. recalls Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL Single Dose Vials (NDC 0641-6042-01), 25
- Hikma Pharmaceuticals USA Inc. recalls Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25
- Sagent Pharmaceuticals Inc recalls Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent
- Hospira Inc. recalls KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake
Other forms on FDA’s list
Ketorolac Tromethamine Tablet shortage questions
Is Ketorolac Tromethamine Tablet in shortage?
Ketorolac Tromethamine Tablet is listed by FDA as being discontinued by at least one maker (updated Apr 20, 2026).
What should I do if I can’t get Ketorolac Tromethamine Tablet?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.